cilostazol has been researched along with metoprolol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bramer, SL; Suri, A | 1 |
| Burgin, K; Daiber, A; Gori, T; Jansen, T; Knorr, M; Kopp, M; Kröller-Schön, S; Münzel, T; Oelze, M; Sartor, D; Scherhag, A; Schulz, E; Stamm, P; Tran, LP; Ullmann, E; Welschof, P | 1 |
1 review(s) available for cilostazol and metoprolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for cilostazol and metoprolol
| Article | Year |
|---|---|
Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Area Under Curve; Cilostazol; Cross-Over Studies; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Metoprolol; Middle Aged; Quinidine; Tetrazoles; Vasodilator Agents | 1999 |
2 other study(ies) available for cilostazol and metoprolol
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Basic in vitro Characterization of the Vasodilatory Potential of 2-Aminoethyl Nitrate Fixed-Dose Combinations with Cilostazol, Metoprolol and Valsartan.
Topics: Animals; Aorta; Cilostazol; Drug Combinations; Drug Synergism; Male; Metoprolol; Mitochondria, Heart; Nitrates; Oxidative Stress; Rats, Wistar; Tetrazoles; Valsartan; Vasodilator Agents | 2018 |